Loading…
IQVIA Holdings Inc. is projected to rise to $310.64 by 2027, a +28% move from its current price of $242.94. IQV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $238.27 | $243.00 | $247.82 | +0.02% |
| Aug 1 | $236.40 | $243.06 | $249.90 | +0.05% |
| Aug 2 | $234.99 | $243.12 | $251.53 | +0.07% |
| Aug 3 | $233.81 | $243.18 | $252.92 | +0.10% |
| Aug 4 | $232.79 | $243.24 | $254.15 | +0.12% |
| Aug 5 | $231.87 | $243.30 | $255.28 | +0.15% |
| Aug 6 | $231.04 | $243.36 | $256.33 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $231.04 | $243.36 | $256.33 | +0.17% |
| Week 2 | $226.51 | $243.77 | $262.36 | +0.34% |
| Week 3 | $223.18 | $244.19 | $267.18 | +0.52% |
| Week 4 | $220.47 | $244.61 | $271.39 | +0.69% |
| Week 5 | $218.16 | $245.03 | $275.21 | +0.86% |
| Week 6 | $216.13 | $245.45 | $278.76 | +1.03% |
| Week 7 | $214.30 | $245.87 | $282.10 | +1.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services.
The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd.
for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.
IQVIA is a health care information and analytics company operating in three business segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The stock is currently trading with a market capitalization of $39.99B and is ranked 356 by market size. It is currently priced at $242.94 per share.
The 30-day forecast hints at upside beyond the current price, with a multi-year path showing substantial upside through 2050. The forecasted averages rise from $242.94 in 2026 to $2,310.02 on average in 2050, with corresponding max values and strong bullish signals later in the period. These figures are estimates and not guarantees; actual results will vary.
The 30-day range to watch is $213.45–$276.51, underscoring near-term volatility within a bullish longer-term trajectory.
A major floor 37.2% below — a decisive break under it would weaken the trend.
The nearest floor, 30.9% below — buyers have tended to step in here.
Resistance now sits 12.2% below — it may act as fresh support.
A major ceiling 0.2% above — clearing it would confirm fresh momentum.
Key IQV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IQV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $205.75 | Buy | $208.07 | Buy |
| MA 10 | $206.40 | Buy | $206.37 | Buy |
| MA 20 | $205.16 | Buy | $202.49 | Buy |
| MA 50 | $188.40 | Buy | $192.73 | Buy |
| MA 100 | $179.09 | Buy | $188.61 | Buy |
| MA 200 | $196.67 | Buy | $189.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.60 | Neutral |
| Stoch RSI (14) | 75.64 | Neutral |
| CCI (20) | 139.41 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.53 | Sell |
| ROC (12) | 2.03 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.50 | Buy |
| Awesome (5,34) | 11.16 | Buy |
| Ultimate (7,14,28) | 57.14 | Neutral |
| Momentum (10) | 5.67 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 207.87 | Buy |
| ADX (14) | 25.46 | Buy |
| ATR (14) | 3.35 | Info |
The 30-day technical picture shows bullish sentiment around IQVIA, with RSI14 at 70 and price momentum supported by the 50-day and 200-day moving averages. The 50-day simple moving average sits at $187.69 and the 200-day simple moving average at $196.63, suggesting near-term price consolidation around these levels. Support is identified at $167.77 while resistance sits at $213.22, framing a near-term trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $156.66 | $242.94 | $325.13 | 0% | Neutral | |
| $254.02 | $310.64 | $397.46 | +28% | Bullish | |
| $298.86 | $372.75 | $490.50 | +53% | Bullish | |
| $307.76 | $390.09 | $524.77 | +61% | Bullish | |
| $326.15 | $419.28 | $574.64 | +73% | Bullish | |
| $372.00 | $484.36 | $674.76 | +99% | Bullish | |
| $407.99 | $537.53 | $759.91 | +121% | Bullish | |
| $485.27 | $646.43 | $926.14 | +166% | Bullish | |
| $543.52 | $731.61 | $1,061.18 | +201% | Bullish | |
| $571.01 | $776.26 | $1,138.94 | +220% | Bullish | |
| $854.69 | $1,214.55 | $1,870.51 | +400% | Bullish | |
| $1,509.90 | $2,310.02 | $3,822.07 | +851% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $156.66 | $242.94 | $284.99 | +0.00% |
| August 2026 | $213.63 | $249.36 | $296.84 | +2.64% |
| September 2026 | $211.59 | $248.43 | $298.56 | -0.37% |
| October 2026 | $214.96 | $253.58 | $307.08 | +2.07% |
| November 2026 | $221.79 | $262.65 | $320.04 | +3.58% |
| December 2026 | $223.26 | $265.34 | $325.13 | +1.02% |
Click any year to see its month-by-month IQV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IQV price prediction for 2026 points to an average of $242.94 (low $156.66, high $325.13) — a potential gain of 0% on today's $242.94. A consolidation phase looks the most probable path here.
In 2027, IQV is projected to trade between $254.02 and $397.46, averaging $310.64 — a potential gain of +28% from today's $242.94. That is up +28% on the projected 2026 average. Momentum favours further upside here.
IQVIA Holdings Inc.'s 2028 outlook centres on $372.75, within a $298.86 to $490.50 range. That is up +20% on the projected 2027 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, IQV could reach as high as $524.77, with a base case around $390.09 and support toward $307.76 — roughly +61% from $242.94. Momentum favours further upside here.
Expect IQV to range from $326.15 to $574.64 through 2030. The $419.28 average target implies a +73% move from current prices. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The IQV price prediction for 2031 points to an average of $484.36 (low $372.00, high $674.76) — a potential gain of +99% on today's $242.94. Momentum favours further upside here.
In 2032, IQV is projected to trade between $407.99 and $759.91, averaging $537.53 — a potential gain of +121% from today's $242.94. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
IQVIA Holdings Inc.'s 2033 outlook centres on $646.43, within a $485.27 to $926.14 range. That is up +20% on the projected 2032 average. That marks a +166% change versus current levels. Momentum favours further upside here.
By 2034, IQV could reach as high as $1,061.18, with a base case around $731.61 and support toward $543.52 — roughly +201% from $242.94. Buyers look set to stay in control over this stretch.
Expect IQV to range from $571.01 to $1,138.94 through 2035. The $776.26 average target implies a +220% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The IQV price prediction for 2040 points to an average of $1,214.55 (low $854.69, high $1,870.51) — a potential gain of +400% on today's $242.94. Buyers look set to stay in control over this stretch.
In 2050, IQV is projected to trade between $1,509.90 and $3,822.07, averaging $2,310.02 — a potential gain of +851% from today's $242.94. That is up +90% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in IQV today (≈ 4.116243 IQV) could be worth
$9,508.6
+$8,508.6 (+851%) by 2050 · US Dollar
Based on the average projected IQV price of $2,310.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IQVwould be worth at today's price.
$1,000 invested in IQV on Jul 28, 2025 (≈ 5.056634 IQV) would be worth
$1,228.46
+$228.46 (+22.8%) today · 1.23× · US Dollar
Based on a IQV entry price of $197.76 vs. today's $242.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $203.9 | $1,191.47 | +19.1% |
| 1 month ago | $191.14 | $1,271.01 | +27.1% |
| 3 months ago | $158.98 | $1,528.12 | +52.8% |
| 6 months ago | $239.76 | $1,013.26 | +1.3% |
| 1 year ago | $197.76 | $1,228.46 | +22.8% |
| All time (5.0y) ago | $247.3 | $982.37 | -1.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IQV forecast.
Our base-case forecast reaches $490.00 around 2032.
Implied market cap at $490.00: $80.65B
The multi-year forecast depicts a strong upside path from the current level. In 2026, the average price is $242.94 with a min of $156.66 and a max of $325.13, and 2026 shows 0% ROI with neutral sentiment. By 2027 the average rises to $310.64, aided by a 27.9% ROI and bullish sentiment.
2028 shows an average of $372.75 (53.4% ROI), and 2029 projects an average of $390.09 (60.6% ROI). By 2030 the forecasted average is $419.28 with a 72.6% ROI, and 2030’s max reaches $574.64 while sentiment remains bullish. The path continues to 2031 ($484.36 avg, 99.4% ROI, max $674.76), 2032 ($537.53 avg, 121.3% ROI, max $759.91), and 2033 ($646.43 avg, 166.1% ROI, max $926.14).
The forecast extends to 2040 with an average of $1,214.55 and a 399.9% ROI (max $1,870.51), and to 2050 with an average of $2,310.02 and an 850.9% ROI (max $3,822.07). All these figures carry bullish sentiment, but they are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $419.28, with a min of $326.15 and a max of $574.64; ROI 72.6%; sentiment bullish.
Forecasts indicate a bullish trajectory with rising averages after 2026 (e.g., 2027 avg $310.64, 2040 avg $1,214.55, 2050 avg $2,310.02; ROI grows to 850.9% by 2050). These are estimates, not guarantees.
Yes. The forecast shows 2029 max $524.77 and 2030 max $574.64, with further upside in 2031 ($674.76 max) and beyond.
RSI14 is 70 with bullish sentiment. The 50-day and 200-day moving averages are $187.69 and $196.63, respectively. The 30-day range is $213.45–$276.51, with support at $167.77 and resistance at $213.22.
The 2050 forecast gives an average of $2,310.02, a max of $3,822.07, and a ROI of 850.9% with bullish sentiment.
IQVIA Holdings Inc. Community Discussion
0Share your IQVIA Holdings Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.